MedPath
HSA Approval

DIALOSA TABLET 3MG

SIN13674P

DIALOSA TABLET 3MG

DIALOSA TABLET 3MG

July 20, 2009

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A10BB12

glimepiride

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

PharmaPath SA

Active Ingredients

GLIMEPIRIDE

3MG

Glimepiride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIALOSA TABLET 3MG - HSA Approval | MedPath